Parker Institute for Cancer Immunotherapy

Other

Parker Institute accelerates development of breakthrough cancer immunotherapies through collaborative research network.

San Francisco, United States · 7+ investments · 5 portfolio companies

Early Stage
Biotech
Healthcare
Headquarters
San Francisco, United States
Founded
2016
Portfolio Companies
5
Total Investments
7
Last Investment
Jul 2025
Geographic Focus
United States

Investment Thesis

Break barriers in cancer immunotherapy research to rapidly develop curative immune therapies.

Parker Institute for Cancer Immunotherapy is an Other based in San Francisco, United States. It has made 7 investments in Biotech and Healthcare, including Georgiamune, Tmunity and Akamis Bio.

Portfolio5

Co-investors19

Sign up to view co-investors

19 co-investors across 22 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×16 · Sovereign Wealth Fund ×1 · Other ×1 · 17 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Parker Institute for Cancer Immunotherapy on Indexed.vc
<a href="https://indexed.vc/investors/parker-institute-for-cancer-immunotherapy"><img src="https://indexed.vc/api/badge/investor/parker-institute-for-cancer-immunotherapy" alt="Parker Institute for Cancer Immunotherapy on Indexed.vc" width="260" height="76" /></a>